Clinical Trial Update: Yinhu Qingwen Granula for the Treatment of Severe CoVID-19 [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Yinhu Qingwen Granula in treating severe COVID-19 has suspended its Phase 2/Phase 3 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Yinhu Qingwen Granula

Snippet

Sponsor: Zhong Wang | Conditions: COVID-19, Severe Pneumonia | Phase 2, Phase 3 | Status: SUSPENDED